In addition to the established risk factors such as age, body mass index and gender, genetic variants in TM6SF2, patatin-like phospholipase domain containing 3 (PNPLA3), glucokinase gene regulator, and many others also confer susceptibility to NAFLD [11, 26–31]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.